u/elise_ramos

the first person to notice was me, months after it started

progress is not linear and nobody’s is

the clothes change before the number does

Slight disagreement: that is a month, not a plateau, and calling it one makes it heavier than it is.

Correcting my own post above — that was week 77, not the week I wrote. Same story, wrong number.

the shortage list is the whole legal hinge and people skip it

the lowest effective dose is a real target and nobody talks about it

the API source is the question nobody asks and everybody should

Tested three lots over a year rather than three vials from one lot. Cost the same and told me something completely different.

Small fix — same supplier, different lot. The two rows in the log are not the same batch.

Have now spent more on testing than on some of the orders. No regrets — the log is the reason I can buy without agonising.

the habits are the part that has to outlive the dose

Right, and reading the actual supply notice rather than the coverage of it saves a fortnight of speculation.

Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter.

Not convinced — the US threads are a different system entirely and importing their advice here does real harm.

Correction: that is the claimed figure, and the measured one is the higher of the two in your own screenshot.

Two years and four months on a tier 3 list. Referral date and every letter kept, which turned out to matter when the service reorganised.

The template is vendor, compound, batch, service, claim, result, and who paid. Every one of those fields exists because a result missing it has been argued about here before.

Did the clothes change before the number did for you too?

What was the non-scale thing that told you first?

the trials that looked at withdrawal are unambiguous about what follows

Adding one thing — decide what maintenance looks like before you arrive at it.

an online consultation that asks you nothing is not a consultation

the habits are the part that has to outlive the dose

Careful, that pricing figure is a headline offer with conditions attached rather than the actual monthly cost.

The shortage list is the legal hinge: the permissions that allow certain compounding to happen at scale are tied to a drug’s shortage status, which changes.

This. Waist measurement kept moving through my longest stall and it was the only thing that kept me sane.

vendor, compound, batch, service, result — that is the template

anders_vermeulen is right that the band matters more than the peak.

Disagreeing with this line: that gap is ordinary variance, not a contradiction between the lab and the certificate.

NHS pathway or private prescription?

compounded is not generic, there is no equivalence claim

How long have you been at goal?

If the report gives a mass spectrum as well as UV purity, say so. Identity and relative quantity are separate claims and the log tracks both.

a plateau is not a failure and it is not a personality

the MHRA supply notices are published, read them before the panic threads

Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.

The habits from the losing phase are what carry it now. That is not inspirational, it is just what happened.

Push back: that is not a plateau, that is maintenance. You have arrived and you are describing it as a failure.

Kept every report as a PDF with the batch in the filename. Two years in, it is the most useful folder I own.

ask what the beyond-use date is based on

Fourth lot from the same supplier in the log now and the band has been tight the whole way. That consistency is the actual finding.

a result with no batch number is about a vial nobody can identify

Adding the boring but useful bit: say whether you paid for it. It is the basis of the whole log.